MedTrace Logo

Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma

NCT01493830 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2016-07-11

No results posted yet for this study

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial studies biomarkers in tumor samples from younger patients with neuroblastoma.

Conditions

Interventions

GENETIC

fluorescence in situ hybridization

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

mutation analysis

GENETIC

protein analysis

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

microscopy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Peter Zage, MD, PhD · Texas Children's Cancer Center

Eligibility

Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2016-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01493830 on ClinicalTrials.gov